One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Annals of the Rheumatic Diseases collection on autoantibodies in the rheumatic diseases: new insights into pathogenesis and the development of novel biomarkers
David S Pisetsky
doi : 10.1136/ard-2023-224692
October 2023 - Volume 82 - 10
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease
Abhishek Abhishek, Sara K Tedeschi, Tristan Pascart, Augustin Latourte, Nicola Dalbeth, Tuhina Neogi, Amy Fuller, Ann Rosenthal, Fabio Becce, Thomas Bardin, Hang-Korng Ea, Georgios Filippou, John Fitzgerald, AnnaMaria Iagnocco, Frédéric Lioté, Geraldine M McCarthy, Roberta Ramonda, Pascal Richette, Francisca Sivera, Mariano Andrés, Edoardo Cipolletta, Michael Doherty, Eliseo Pascual, Fernando Perez-Ruiz, Alexander So, Tim L Jansen, Minna J Kohler, Lisa K Stamp, Janeth Yinh, Antonella Adinolfi, Uri Arad, Thanda Aung, Eva Benillouche, Alessandra Bortoluzzi, Jonathan Dau, Ernest Maningding, Meika A Fang, Fabiana A Figus, Emilio Filippucci, Janine Haslett, Matthijs Janssen, Marian Kaldas, Maryann Kimoto, Kelly Leamy, Geraldine M Navarro, Piercarlo Sarzi-Puttini, Carlo Scirè, Ettore Silvagni, Silvia Sirotti, John R Stack, Linh Truong, Chen Xie, Chio Yokose, Alison M Hendry, Robert Terkeltaub, William J Taylor, Hyon K Choi
doi : 10.1136/ard-2023-224575
2023 ACR/EULAR antiphospholipid syndrome classification criteria
Medha Barbhaiya, Stephane Zuily, Ray Naden, Alison Hendry, Florian Manneville, Mary-Carmen Amigo, Zahir Amoura, Danieli Andrade, Laura Andreoli, Bahar Artim-Esen, Tatsuya Atsumi, Tadej Avcin, Michael H Belmont, Maria Laura Bertolaccini, D Ware Branch, Graziela Carvalheiras, Alessandro Casini, Ricard Cervera, Hannah Cohen, Nathalie Costedoat-Chalumeau, Mark Crowther, Guilherme de Jesús, Aurelien Delluc, Sheetal Desai, Maria De Sancho, Katrien M Devreese, Reyhan Diz-Kucukkaya, Ali Duarte-GarcÃa, Camille Frances, David Garcia, Jean-Christophe Gris, Natasha Jordan, Rebecca K Leaf, Nina Kello, Jason S Knight, Carl Laskin, Alfred I Lee, Kimberly Legault, Steve R Levine, Roger A Levy, Maarten Limper, Michael D Lockshin, Karoline Mayer-Pickel, Jack Musial, Pier Luigi Meroni, Giovanni Orsolini, Thomas L Ortel, Vittorio Pengo, Michelle Petri, Guillermo Pons-Estel, Jose A Gomez-Puerta, Quentin Raimboug, Robert Roubey, Giovanni Sanna, Surya V Seshan, Savino Sciascia, Maria G Tektonidou, Angela Tincani, Denis Wahl, Rohan Willis, Cécile Yelnik, Catherine Zuily, Francis Guillemin, Karen Costenbader, Doruk Erkan
doi : 10.1136/ard-2023-224609
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)
Bita Shakoory, Ashley Geerlinks, Marta Wilejto, Kate Kernan, Melissa Hines, Micol Romano, David Piskin, Angelo Ravelli, Rashmi Sinha, Daniel Aletaha, Carl Allen, Hamid Bassiri, Edward M Behrens, Joseph Carcillo, Linda Carl, Winn Chatham, Jeffrey I Cohen, Randy Q Cron, Erik Drewniak, Alexei A Grom, Lauren A Henderson, Annacarin Horne, Michael B Jordan, Kim E Nichols, Grant Schulert, Sebastiaan Vastert, Erkan Demirkaya, Raphaela Goldbach-Mansky, Fabrizio de Benedetti, Rebecca A Marsh, Scott W Canna
doi : 10.1136/ard-2023-224123
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
Mikkel Østergaard, Ronald F van Vollenhoven, Anna Rudin, Merete Lund Hetland, Marte Schrumpf Heiberg, Dan C Nordström, Michael T Nurmohamed, Bjorn Gudbjornsson, Lykke Midtbøll Ørnbjerg, Pernille Bøyesen, Kristina Lend, Kim Hørslev-Petersen, Till Uhlig, Tuulikki Sokka, Gerdur Grondal, Simon Krabbe, Joakim Lindqvist, Inger Gjertsson, Daniel Glinatsi, Meliha Crnkic Kapetanovic, Anna-Birgitte Aga, Francesca Faustini, Pinja Parmanne, Tove Lorenzen, Cagnotto Giovanni, Johan Back, Oliver Hendricks, Daisy Vedder, Tuomas Rannio, Emma Grenholm, Maud Kristine Ljoså, Eli Brodin, Hanne Lindegaard, Annika Söderbergh, Milad Rizk, Alf Kastbom, Per Larsson, Line Uhrenholt, Søren Andreas Just, David J Stevens, Trine Bay Laurbjerg, Gunnstein Bakland, Inge Christoffer Olsen, Espen A Haavardsholm, Jon Lampa
doi : 10.1136/ard-2023-224116
Cost–utility analysis of tapering strategies of biologicals in rheumatoid arthritis patients in the Netherlands
Luuk van Esveld, Juul M Cox, T Martijn Kuijper, Tessa M Bosch, Angelique EAM Weel-Koenders
doi : 10.1136/ard-2023-224190
Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial
Abdullah Ali Hadi Almayali, Maarten Boers, Linda Hartman, Daniela Opris, Reinhard Bos, Marc R Kok, Jose AP Da Silva, Ed Griep, Ruth Klaasen, Cornelia F Allaart, Paul Baudoin, Hennie G Raterman, Zoltan Szekanecz, Frank Buttgereit, Pavol Masaryk, Willem Lems, Yvo Smulders, Maurizio Cutolo, Marieke M ter Wee
doi : 10.1136/ard-2023-223977
Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares
Doua F Azzouz, Ze Chen, Peter M Izmirly, Lea Ann Chen, Zhi Li, Chongda Zhang, David Mieles, Kate Trujillo, Adriana Heguy, Alejandro Pironti, Greg G Putzel, Dominik Schwudke, David Fenyo, Jill P Buyon, Alexander V Alekseyenko, Nicolas Gisch, Gregg J Silverman
doi : 10.1136/ard-2023-223929
SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy
Xin-yu Zhao, Shuang-shuang Li, Ying-xin He, Li-jie Yan, Fu Lv, Qi-meng Liang, Yu-hui Gan, Li-pei Han, Hong-de Xu, Yong-chun Li, Yuan-yuan Qi
doi : 10.1136/ard-2023-224242
Incidence of primary large vessel vasculitis in Norfolk, UK from 2011 to 2020
Chetan B Mukhtyar, Clare Beadsmoore, Fiona L Coath, Georgina Ducker, Sarah Fordham, Katherine Sisson, Cee Y Yong, Richard A Watts
doi : 10.1136/ard-2023-224191
Single-cell transcriptome analysis profiles cellular and molecular alterations in submandibular gland and blood in IgG4-related disease
Yanmei Li, Zhiqin Wang, Feng Han, Mei Zhang, Tong Yang, Ming Chen, Jun Du, Yin Wang, Li Zhu, Hou Hou, Yanxia Chang, Lin Han, Xing Lyu, Na Zhang, Wenwen Sun, Zhigang Cai, Wei Wei
doi : 10.1136/ard-2023-224363
Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study
Annemarie Lyng Lyng Svensson, Hanne-Dorthe Emborg, Lars Erik Bartels, Torkell Ellingsen, Thomas Adelsten, René Cordtz, Lene Dreyer, Niels Obel
doi : 10.1136/ard-2023-223974
Rare mimicker of sacroiliitis
Olivier Fakih, Jean-Charles Balblanc, Anne Lohse
doi : 10.1136/ard-2023-224164
Correspondence on ‘Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
Tanaz A Kermani
Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’
Sarthak Gupta, Shuichiro Nakabo, Jun Chu, Sarfaraz Hasni, Mariana J Kaplan
Correspondence to ‘Bacterial citrullinated epitopes generated by Porphyromonas gingivalis infection—a missing link for ACPA production
Kevin Sheng-Kai Ma, Cho-Han Chiang, Yi-Wen Chen, Li-Tzu Wang
Methotrexate prolongs TNF inhibitor survival, but only in autoantibody-positive rheumatoid arthritis: a validation study
Elise van Mulligen, Annette van der Helm-van Mil, Pascal Hendrik Pieter de Jong
Correspondence on ‘Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases
Gonçalo Boleto, Carolla El Chamieh, Lucie Biard, Isabelle Koné-Paut, Veronique Hentgen, Guilaine Boursier, Guillaume Sarrabay, Patrice Cacoub, Isabelle Touitou, David Saadoun
Correction: Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label randomised controlled ORAL Surveillance trial
Correction: Combined therapy of prednisone and mTOR inhibitor sirolimus for treating retroperitoneal fibrosis
